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A 69-year-old man presented with 4-month’s history ofcough, bloody sputum, and exertional dyspnea. He
smoked for 50 years. His past medical history was unremark-
able. The physical examination was normal. The complete
blood count and the tumor markers were in the normal range.
C-reactive protein level was 10.5 mg/liter. The tuberculosis
skin test was negative. Autoantibody assessment was nega-
tive for antinuclear antibody and antineutrophil cytoplasmic
antibody. The chest radiograph showed a narrow central
airway. Chest computed tomography (Figure 1) demonstrated
a thickened central airway wall from the aortic arch level to
the carina level, nodular infiltrations in the right lung, and
enlargement of mediastinal lymph nodes. Bronchoscopy
(Figure 2) revealed cauliflower-like neoplasms with an irreg-
ular surface around the central airway wall which began 5 cm
from the glottis. The mucosa was friable, red, and hemor-
rhagic. There was approximately a 60% stenosis of the
airway. The histopathology of the transbronchial biopsy spec-
imen revealed a diffuse proliferation of small round-to-oval
cells with high N/C ratio, felt to be small cell carcinoma.
Immunohistochemistry staining was positive for myeloid
markers including myeloperoxidase, leukocyte common an-
tigen, and lysozyme, negative for CD3, CD20, CD79,
CD45RO, establishing a diagnosis of the central airway
granulocytic sarcoma. The patient refused further examina-
tion and therapy. Two months later, the patient developed
stridor and worsening dyspnea. To relieve his symptoms, the
patient was treated by stent placement in the central airway.
The complete blood count revealed a leukocyte count of
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FIGURE 1. Chest computed tomography demonstrated a
thickened central airway wall from the aortic arch level to
the carina level.
FIGURE 2. Bronchoscopy revealed cauliflower-like neo-
plasms with an irregular surface around the central airway
wall.
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2.8  109/liter, hemoglobin 80 g/liter, and platelet 99 
109/liter. Bone marrow examination revealed 60% abnormal
granulocytes. Immunophenotypic analysis of the blasts was
positive for cluster differentiation 38(CD38), CD117, CD33,
CD13, human leukocyte antigen (locus) DR (HLA-DR). A
diagnosis of acute myeloid leukemia (FAB M2a) was con-
firmed. The patient refused chemotherapy and died of respi-
ratory failure.
Granulocytic sarcoma is a rare extramedullary tumor
composed of immature granulocytic precursor cells. It may
occur in leukemia, other myeloproliferative disorders, or
isolated without overt hematologic disease. It most com-
monly develops in the bone, soft tissue, and skin. Pulmonary
involvement is uncommon but may involve the parenchyma,
pleura, mediastinum, and airways. We present a case of
central airway infiltration as the primary presentation of the
underlying leukemia. Granulocytic sarcomas occur in pa-
tients of all ages. The pathologic diagnosis of granulocytic
sarcoma sometimes can be challenging. The presence of
eosinophils or other granulocytes should raise a suspicion for
granulocytic sarcoma.1 However, special stains such as my-
eloperoxidase, chloroacetate esterase, lysozyme, and immu-
nophenotype (such as CD43, CD117, CD68, CD163, CD3,
and CD20) are essential.2 The diagnosis of granulocytic
sarcoma is ominous, as the tumors are seen almost exclu-
sively in patients with an aggressive underlying hematologic
malignancy. The mean interval between tumor and death has
been reported as 4.4 months with acute myelogenous leuke-
mia and 3.8 months with chronic granulocytic leukemia.3
When a diagnosis of isolated granulocytic sarcoma is made,
a prompt and thorough search for underlying hematologic
malignancy should be initiated.
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